|4Jan 23, 5:10 PM ET

Cadoret-Manier Onaiza 4

4 · Ventyx Biosciences, Inc. · Filed Jan 23, 2024

Insider Transaction Report

Form 4
Period: 2024-01-21
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-21+20,00020,000 total
    Exercise: $1.97Exp: 2034-01-21Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest on the one-year anniversary of January 21, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan, the "Plan") through such date, provided that in the event of a Change in Control (as such term is defined in the Plan), one hundred percent (100%) of the then-unvested and outstanding shares subject to the Option will accelerate and fully vest, subject to the reporting person continuing to be an Outside Director (as the term is defined in the Company's Amended and Restated Outside Director Compensation Policy) through the date of the Change in Control.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION